Pharmacy

Here are key areas that will trend in 2020, particularly in regard to population health programs.

A new survey reveals how patients are struggling to navigating the complex healthcare system and what concerns they have about it.

Patients may miss out on savings and making informed treatment decisions.

Preventive care is key to overcome the treatment and management challenges of this chronic condition.

New report examines opioid-related malpractice claims to identify risk factors, warning signs, and vulnerabilities in pain management.

HOPE program can serve as a model for treating patients at risk for addiction.

As more healthcare organizations look to curb hospital readmission rates, they are taking a hard look at one of medicine’s most complex conditions-cancer.

Runaway drug costs call for a new approach to care management, such as a different way of thinking about managing the health of the employee population.

There are a variety of ways, but a multi-pronged approach is best.

Drug shortages are a major problem and can have a negative impact on patient care and public health. Here, Dan Kistner, PharmD, senior vice president, pharmacy solutions for Vizient, talks about the top 8 reasons that drug shortages can occur. 

Strategies to get the most value out of current and future oncology payment models

Phase 3 drugs show innovative approaches to cancer treatment.

Kootenai Care Network uses a population health management platform to reduce the burden on payers and providers.

Providing uniform and quality service to all patients, no matter their demographic.

Study finds use, costs for new migraine prevention meds projected to triple by 2020.

The opioid crisis cost the U.S. billions. Find out the impact on the future economy.

Despite the trust between physicians and patients, some physicians believe another prescription drug crisis may arise.

The state’s desired savings and efficiencies can be realized, but will likely take some effort.

Consumers will depend on the internet to research prescriptions and medical devices rather than a doctor’s referral.

First-of-its-kind survey brings clarity to the effect of 340B and Medicaid programs on each other through comprehensive state analysis.

An ingestible sensor allows physicians to remotely monitor TB patients’ medicine.

Why cost and treatment length are some of the biggest concerns for drug manufacturers.

Antimicrobial stewardship is a key strategy to combat the emergence of drug resistance.

Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?

One key opinion leader calls on healthcare to ensure access to gene therapies.